NEW YORK, May 30, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Herpes Market to 2018 – Genericization Compels Competitors Seeking Differentiation …

Osiris Therapeutics says that Canadian health regulators have approved its treatment for acute graft-versus host disease

An FDA advisory panel said a study of Vyndaqel for familial amyloid polyneuropathy did not provide proof of its benefit, but that proof may not be necessary.

MANILA, Philippines – Two kilograms of marijuana were seized from a suspected drug pusher in Quezon City on Thursday night.

In the fall fo 2010, Pfizer trumpeted the purchase of a small, privately held drugmaker called FoldRx Pharmaceuticals, which developed its own discovery platform technology and was completing testing for it lead compound. The medication, which is calle…

Researchers in the United Kingdom have determined that azithromycin, a broad-spectrum antibiotic that also has anti-inflammatory properties, can be an effective treatment option for patients suffering from bronchiolitis obliterans syndrome (BOS), a lif…

Drug reviewers on Tuesday recommended rejecting a Pfizer Inc drug because the data did not prove it worked well in treating a rare neurodegenerative disease. The U.S. Food and Drug Administration staff …

The study from Duke University suggest the drug could help the 90 per cent of men over 70 who have problems with an enlarged prostate.

There is great news for parents suffering the harrowing ordeal of their child needing a bone marrow transplant. The announcement came from Osiris Therapeutics Inc. (NASDAQ: OSIR) on Friday that Health Canada has approved its groundbreaking stem cell th…

A investigational drug derived from milk thistle seeds helped save the lives — and livers — of four people in the Washington, D.C., area who accidentally ate toxic mushrooms last fall. If approved, it could become standard treatment, experts say.